As of July 1, 2017 Dr. Patricia Ganz will assume editorial leadership of one of the oldest and most internationally respected oncology journals, JNCI: Journal of the National Cancer Institute.
Ganz is director of Cancer Prevention & Control Research at UCLA’s Jonsson Comprehensive Cancer Center, and a professor of health policy and management in the Fielding School of Public Health and professor of medicine in the David Geffen School of Medicine at UCLA. An accomplished medical oncologist and advocate for improving the quality of cancer care from prevention through survivorship, Ganz is a pioneer in the assessment of quality of life in cancer patients and has focused much of her clinical and research efforts in breast cancer and its prevention.
Ganz will replace Dr. Carmen Allegra, editor-in-chief of JNCI since 2012. This move was precipitated by Allegra’s recent assignment at the National Cancer Institute as the head of gastrointestinal therapeutics at the Clinical Investigations Branch at the Cancer Therapy Evaluation Program. Allegra will continue his engagement with JNCI as deputy editor.
“I look forward to taking on this new role and working with my colleagues at JNCI to enhance the experience of authors and reviewers during the editorial process,” said Ganz. “I welcome your suggestions for improving any other aspects of JNCI: Journal of the National Cancer Institute.”
As editor-in-chief, Ganz is also responsible for JNCI Monographs, a supplement publication that provides a venue for conference proceedings or topic areas where a series of related articles serve a scientific purpose. During the past two years, JNCI has developed a series of virtual collections curated from prior publications; these thematically organized collections focus on timely selected topics and are featured online with free access for several months.
“Dr. Ganz has served as deputy editor of JNCI for five years and we are delighted that she has now accepted the position of editor-in-chief of the journal, said Fiona Williams, senior publisher for the JNCI portfolio at Oxford University Press. “She brings a wealth of experience, and we look forward to working with her to further strengthen JNCI’s reputation in the oncology community.”
JNCI publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, JNCI has been ranked as one of the most-cited original research cancer journals by Clarivate Analytics (formerly the Institute of Scientific Information) in its annual Journal Citation Reports.
